iqus limited

Live MatureSmallHealthy

iqus limited Company Information

Share IQUS LIMITED

Company Number

04070870

Shareholders

m3 medical holdings ltd

Group Structure

View All

Industry

Business and domestic software development

 

Registered Address

20a appleton court, calder business park, wakefield, west yorkshire, WF2 7AR

iqus limited Estimated Valuation

£3.1m

Pomanda estimates the enterprise value of IQUS LIMITED at £3.1m based on a Turnover of £3.3m and 0.93x industry multiple (adjusted for size and gross margin).

iqus limited Estimated Valuation

£6.7m

Pomanda estimates the enterprise value of IQUS LIMITED at £6.7m based on an EBITDA of £1.2m and a 5.7x industry multiple (adjusted for size and gross margin).

iqus limited Estimated Valuation

£4.6m

Pomanda estimates the enterprise value of IQUS LIMITED at £4.6m based on Net Assets of £1.9m and 2.38x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Iqus Limited Overview

Iqus Limited is a live company located in wakefield, WF2 7AR with a Companies House number of 04070870. It operates in the business and domestic software development sector, SIC Code 62012. Founded in September 2000, it's largest shareholder is m3 medical holdings ltd with a 100% stake. Iqus Limited is a mature, small sized company, Pomanda has estimated its turnover at £3.3m with healthy growth in recent years.

View Sample
View Sample
View Sample

Iqus Limited Health Check

Pomanda's financial health check has awarded Iqus Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 2 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

5 Strong

positive_score

3 Regular

positive_score

2 Weak

size

Size

annual sales of £3.3m, make it smaller than the average company (£4.6m)

£3.3m - Iqus Limited

£4.6m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 11%, show it is growing at a similar rate (10.2%)

11% - Iqus Limited

10.2% - Industry AVG

production

Production

with a gross margin of 73.3%, this company has a comparable cost of product (72%)

73.3% - Iqus Limited

72% - Industry AVG

profitability

Profitability

an operating margin of 26.5% make it more profitable than the average company (3.4%)

26.5% - Iqus Limited

3.4% - Industry AVG

employees

Employees

with 27 employees, this is below the industry average (42)

27 - Iqus Limited

42 - Industry AVG

paystructure

Pay Structure

on an average salary of £47.1k, the company has a lower pay structure (£71.7k)

£47.1k - Iqus Limited

£71.7k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £121.7k, this is equally as efficient (£122.3k)

£121.7k - Iqus Limited

£122.3k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 38 days, this is earlier than average (58 days)

38 days - Iqus Limited

58 days - Industry AVG

creditordays

Creditor Days

There is insufficient data available for this Key Performance Indicator!

- - Iqus Limited

- - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Iqus Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 74 weeks, this is more cash available to meet short term requirements (17 weeks)

74 weeks - Iqus Limited

17 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 51.2%, this is a lower level of debt than the average (63.1%)

51.2% - Iqus Limited

63.1% - Industry AVG

IQUS LIMITED financials

EXPORTms excel logo

Iqus Limited's latest turnover from December 2023 is £3.3 million and the company has net assets of £1.9 million. According to their latest financial statements, Iqus Limited has 27 employees and maintains cash reserves of £2.5 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover3,286,0713,083,2772,783,8102,433,8272,279,4132,115,2671,816,5641,535,1051,346,8852,372,6421,338,047659,322826,806730,324
Other Income Or Grants
Cost Of Sales876,005782,823821,656773,308772,498735,556533,938342,527365,251645,031385,236184,560223,037185,537
Gross Profit2,410,0662,300,4541,962,1541,660,5191,506,9151,379,7111,282,6261,192,578981,6341,727,611952,811474,762603,768544,788
Admin Expenses1,539,0251,398,8091,142,714887,551796,594695,591746,498458,308516,7971,285,138478,124166,666454,549389,935-241,141
Operating Profit871,041901,645819,440772,968710,321684,120536,128734,270464,837442,473474,687308,096149,219154,853241,141
Interest Payable36599
Interest Receivable21,9128781,2242,6212,5867,82420,6078,8996,4135,1123,7202,8091,942670
Pre-Tax Profit892,953902,523819,075774,192712,843686,706543,952754,877473,736448,886479,799311,816152,027156,794241,811
Tax-209,402-234,177-155,294-147,097-135,440-130,474-103,402-150,975-94,747-94,266-110,354-74,836-39,527-43,902-67,707
Profit After Tax683,551668,346663,781627,095577,403556,232440,550603,902378,989354,620369,445236,980112,500112,892174,104
Dividends Paid800,000800,0001,000,0002,000,00062,500
Retained Profit683,551668,346-136,219-172,905577,403-443,768-1,559,450541,402378,989354,620369,445236,980112,500112,892174,104
Employee Costs1,270,6491,221,4151,180,1171,000,023889,810781,298687,752517,476705,8961,194,428689,945366,030466,001406,759
Number Of Employees2731312725231916132213798
EBITDA*1,173,3971,132,6751,009,000867,417791,395750,366568,473744,202474,961459,877480,380313,125152,963158,549246,773

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets21,56610,42214,28725,33844,44649,37764,35311,59321,62617,40427,07513,92512,3255,3346,844
Intangible Assets1,000,7571,061,340859,112698,010473,936259,705158,42686,856
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets1,022,3231,071,762873,399723,348518,382309,082222,77998,44921,62617,40427,07513,92512,3255,3346,844
Stock & work in progress
Trade Debtors344,898956,473526,145249,080276,895307,228237,168243,637227,619437,991232,550106,491142,290121,79486,732
Group Debtors
Misc Debtors50,43055,24217,32454,47921,1651,17518,191102,732
Cash2,513,1661,307,1701,194,8571,282,4601,551,1311,007,4081,309,0842,834,1972,166,1411,393,5791,171,670873,044614,840508,565268,161
misc current assets
total current assets2,908,4942,318,8851,738,3261,586,0191,849,1911,315,8111,564,4433,180,5662,393,7601,831,5701,404,220979,535757,130630,359354,893
total assets3,930,8173,390,6472,611,7252,309,3672,367,5731,624,8931,787,2223,279,0152,415,3861,848,9741,431,295993,460769,455635,693361,737
Bank overdraft
Bank loan
Trade Creditors 672,956484,852420,317354,658368,080348,377187,221
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities1,761,3271,893,5761,884,4961,475,8161,399,4691,269,3671,001,817978,314
total current liabilities1,761,3271,893,5761,884,4961,475,8161,399,4691,269,3671,001,817978,314672,956484,852420,317354,658368,080348,377187,221
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions249,989261,121159,625129,72891,37656,20142,31219,6692,8003,4814,9572,2261,779220312
total long term liabilities249,989261,121159,625129,72891,37656,20142,31219,6692,8003,4814,9572,2261,779220312
total liabilities2,011,3162,154,6972,044,1211,605,5441,490,8451,325,5681,044,129997,983675,756488,333425,274356,884369,859348,597187,533
net assets1,919,5011,235,950567,604703,823876,728299,325743,0932,281,0321,739,6301,360,6411,006,021636,576399,596287,096174,204
total shareholders funds1,919,5011,235,950567,604703,823876,728299,325743,0932,281,0321,739,6301,360,6411,006,021636,576399,596287,096174,204
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit871,041901,645819,440772,968710,321684,120536,128734,270464,837442,473474,687308,096149,219154,853241,141
Depreciation10,60510,85718,86131,13137,06131,09714,9749,93210,12417,4045,6935,0293,7443,6965,632
Amortisation291,751220,173170,69963,31844,01335,14917,371
Tax-209,402-234,177-155,294-147,097-135,440-130,474-103,402-150,975-94,747-94,266-110,354-74,836-39,527-43,902-67,707
Stock
Debtors-616,387468,246239,9105,499-10,34353,044-91,010118,750-210,372205,441126,059-35,79920,49635,06286,732
Creditors-672,956188,10464,53565,659-13,42219,703161,156187,221
Accruals and Deferred Income-132,2499,080408,68076,347130,102267,55023,503978,314
Deferred Taxes & Provisions-11,132101,49629,89738,35235,17513,88922,64316,869-681-1,4762,7314471,559-92312
Cash flow from operations1,437,001540,8281,052,373829,520831,575848,287602,227796,704778,009223,229312,357261,113114,202240,649279,867
Investing Activities
capital expenditure-158,287-156,834-84,792-14,346-7,733-18,843-6,629-10,735-2,186-12,476
Change in Investments
cash flow from investments-158,287-156,834-84,792-14,346-7,733-18,843-6,629-10,735-2,186-12,476
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue21,511100
interest21,912878-3651,2242,5222,5867,82420,6078,8996,4135,1123,7202,8091,942670
cash flow from financing21,912878-3651,2242,5222,58629,33520,6078,8996,4135,1123,7202,8091,942770
cash and cash equivalents
cash1,205,996112,313-87,603-268,671543,723-301,676-1,525,113668,056772,562221,909298,626258,204106,275240,404268,161
overdraft
change in cash1,205,996112,313-87,603-268,671543,723-301,676-1,525,113668,056772,562221,909298,626258,204106,275240,404268,161

iqus limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for iqus limited. Get real-time insights into iqus limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Iqus Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for iqus limited by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other small companies, companies in WF2 area or any other competitors across 12 key performance metrics.

iqus limited Ownership

IQUS LIMITED group structure

Iqus Limited has no subsidiary companies.

Ultimate parent company

M3 INC

#0043974

2 parents

IQUS LIMITED

04070870

IQUS LIMITED Shareholders

m3 medical holdings ltd 100%

iqus limited directors

Iqus Limited currently has 2 directors. The longest serving directors include Mr Akihiko Tomaru (Jan 2017) and Mr Anton Richter (May 2021).

officercountryagestartendrole
Mr Akihiko TomaruEngland52 years Jan 2017- Director
Mr Anton RichterEngland49 years May 2021- Director

P&L

December 2023

turnover

3.3m

+7%

operating profit

871k

-3%

gross margin

73.4%

-1.7%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

1.9m

+0.55%

total assets

3.9m

+0.16%

cash

2.5m

+0.92%

net assets

Total assets minus all liabilities

iqus limited company details

company number

04070870

Type

Private limited with Share Capital

industry

62012 - Business and domestic software development

incorporation date

September 2000

age

25

incorporated

UK

ultimate parent company

M3 INC

accounts

Full Accounts

last accounts submitted

December 2023

previous names

N/A

accountant

-

auditor

MALCOLMS JONES & CO LIMITED

address

20a appleton court, calder business park, wakefield, west yorkshire, WF2 7AR

Bank

-

Legal Advisor

-

iqus limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to iqus limited.

iqus limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for IQUS LIMITED. This can take several minutes, an email will notify you when this has completed.

iqus limited Companies House Filings - See Documents

datedescriptionview/download